BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18165398)

  • 1. Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure.
    Reeves MF; Lohr PA; Harwood BJ; Creinin MD
    Obstet Gynecol; 2008 Jan; 111(1):106-12. PubMed ID: 18165398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention.
    Reeves MF; Fox MC; Lohr PA; Creinin MD
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):104-9. PubMed ID: 19517421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial thickness after misoprostol use for early pregnancy failure.
    Creinin MD; Harwood B; Guido RS; Fox MC; Zhang J;
    Int J Gynaecol Obstet; 2004 Jul; 86(1):22-6. PubMed ID: 15207665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial thickness and serum beta-hCG as predictors of the effectiveness of oral misoprostol in early pregnancy failure.
    El-Baradie SMY; El-Said MH; Ragab WS; Elssery KM; Mahmoud M
    J Obstet Gynaecol Can; 2008 Oct; 30(10):877-881. PubMed ID: 19038070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early pregnancy failure: factors affecting successful medical treatment.
    Odeh M; Tendler R; Kais M; Maximovsky O; Ophir E; Bornstein J
    Isr Med Assoc J; 2010 Jun; 12(6):325-8. PubMed ID: 20928983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy failure--current management concepts.
    Creinin MD; Schwartz JL; Guido RS; Pymar HC
    Obstet Gynecol Surv; 2001 Feb; 56(2):105-13. PubMed ID: 11219590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound evaluation of the endometrium after medical termination of pregnancy.
    Cowett AA; Cohen LS; Lichtenberg ES; Stika CS
    Obstet Gynecol; 2004 May; 103(5 Pt 1):871-5. PubMed ID: 15121559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment with misoprostol for early failure of pregnancies after assisted reproductive technology: a promising treatment option.
    Machtinger R; Stockheim D; Seidman DS; Lerner-Geva L; Dor J; Schiff E; Shulman A
    Fertil Steril; 2009 May; 91(5):1881-5. PubMed ID: 18455163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of introducing medical management on conservative and surgical management for early pregnancy miscarriage.
    Black KI; de Vries BS; Moses F; Pelosi M; Cong A; Ludlow J
    Aust N Z J Obstet Gynaecol; 2017 Feb; 57(1):93-98. PubMed ID: 28251638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between uterine position and transvaginal misoprostol treatment for early pregnancy failure.
    Chill HH; Malyanker N; Karavani G; Haj-Yahya R; Herzberg S; Bahar R; Shveiky D; Dior UP
    J Obstet Gynaecol Res; 2018 Feb; 44(2):248-252. PubMed ID: 29094502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual versus vaginal misoprostol for the management of missed abortion.
    Tanha FD; Feizi M; Shariat M
    J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
    Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
    Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol in the management of missed abortion.
    Herabutya Y; O-Prasertsawat P
    Int J Gynaecol Obstet; 1997 Mar; 56(3):263-6. PubMed ID: 9127159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of βhCG monitoring in the follow-up of medical management of miscarriage.
    Petersen SG; Perkins AR; Gibbons KS; Bertolone JI; Mahomed K
    Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):358-365. PubMed ID: 28345139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of repeat misoprostol dose in the management of early pregnancy failure.
    Rottenstreich A; Levin G; Ben Shushan A; Yagel S; Porat S
    Arch Gynecol Obstet; 2019 Nov; 300(5):1287-1293. PubMed ID: 31422461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage.
    Sahin HG; Sahin HA; Kocer M
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):141-4. PubMed ID: 11763977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure.
    Demetroulis C; Saridogan E; Kunde D; Naftalin AA
    Hum Reprod; 2001 Feb; 16(2):365-9. PubMed ID: 11157836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial.
    Graziosi GC; Bruinse HW; Reuwer PJ; van Kessel PH; Westerweel PE; Mol BW
    Hum Reprod; 2005 Aug; 20(8):2340-7. PubMed ID: 15831508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of misoprostol in the termination of missed abortion].
    Szymańska M; Suchońska B; Ziółkowska K; Bablok L
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):307-12. PubMed ID: 15537276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.